Daruka Mahadevan Selected Research

Daruka Mahadevan Research Topics

Disease

59	Neoplasms (Cancer) 02/2024 - 01/2003
11	Lymphoma (Lymphomas) 11/2018 - 12/2005
9	Adenocarcinoma 01/2024 - 12/2006
9	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2018 - 05/2011
7	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 06/2009
6	Glioblastoma (Glioblastoma Multiforme) 03/2024 - 01/2008
6	Pancreatic Neoplasms (Pancreatic Cancer) 01/2024 - 01/2003
5	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 12/2006
5	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 09/2007
4	Multiple Myeloma 01/2022 - 03/2013
4	B-Cell Lymphoma (Lymphoma, B Cell) 12/2018 - 06/2012
4	Carcinogenesis 12/2018 - 03/2003
3	Polyploidy 02/2024 - 04/2011
3	Breast Neoplasms (Breast Cancer) 10/2019 - 01/2004
3	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 01/2003
3	Aneuploidy (Aneuploid) 11/2018 - 01/2014
3	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 11/2017 - 04/2013
3	T-Cell Lymphoma (Lymphoma, T Cell) 09/2015 - 01/2013
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 06/2012 - 04/2011
2	Lung Neoplasms (Lung Cancer) 01/2023 - 01/2020
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 07/2016
2	Neurofibrosarcoma (MPNST) 01/2022 - 09/2019
2	Carcinoma (Carcinomatosis) 01/2020 - 06/2009
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 11/2018
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2018 - 07/2016
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 02/2015 - 01/2015
2	Leukemia 04/2010 - 10/2004
2	Nervous System Diseases (Neurological Disorders) 09/2007 - 01/2006
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2006 - 10/2004
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2006 - 02/2005
1	Melanoma (Melanoma, Malignant) 01/2022
1	Acoustic Neuroma (Acoustic Neurinoma) 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Schwannomatosis 01/2022
1	Neurofibromatosis 1 (Neurofibromatosis Type I) 01/2022
1	Neurofibromatoses (Neurofibromatosis) 01/2022
1	Plexiform Neurofibroma 01/2022

Drug/Important Bio-Agent (IBA)

9	MLN 8237IBA 12/2018 - 04/2011
8	Aurora KinasesIBA 12/2018 - 01/2003
7	Biomarkers (Surrogate Marker)IBA 01/2024 - 11/2009
7	Phosphotransferases (Kinase)IBA 09/2017 - 01/2003
6	Monoclonal AntibodiesIBA 01/2017 - 12/2006
5	Gemcitabine FDA Link 12/2022 - 03/2009
5	Immune Checkpoint InhibitorsIBA 01/2022 - 07/2016
5	Rituximab (Mabthera)FDA Link 12/2018 - 04/2012
4	CytokinesIBA 01/2023 - 10/2006
4	Aurora Kinase AIBA 12/2018 - 01/2014
4	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 02/2015 - 05/2009
3	Bevacizumab (Avastin)FDA Link 01/2022 - 10/2017
3	Vincristine (Oncovin)FDA LinkGeneric 12/2018 - 04/2012
3	Cisplatin (Platino)FDA LinkGeneric 12/2018 - 01/2013
3	Etoposide (VP 16)FDA LinkGeneric 12/2018 - 01/2013
3	Docetaxel (Taxotere)FDA Link 06/2012 - 04/2011
3	Proteins (Proteins, Gene)FDA Link 04/2012 - 09/2004
3	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 09/2008 - 01/2003
2	Cell-Free Nucleic AcidsIBA 01/2024 - 01/2020
2	tilsotolimodIBA 12/2022 - 01/2022
2	Epirubicin (Ellence)FDA LinkGeneric 01/2022 - 12/2009
2	AntimetabolitesIBA 01/2022 - 09/2017
2	pembrolizumabIBA 01/2022 - 01/2022
2	LigandsIBA 12/2020 - 12/2006
2	Circulating Tumor DNAIBA 03/2020 - 01/2019
2	Cell Adhesion MoleculesIBA 12/2019 - 02/2015
2	RNA (Ribonucleic Acid)IBA 12/2019 - 10/2019
2	Carcinoembryonic AntigenIBA 12/2019 - 02/2015
2	Protein Kinases (Protein Kinase)IBA 12/2018 - 04/2003
2	PlatinumIBA 12/2018 - 09/2017
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 11/2018 - 04/2010
2	ublituximabIBA 04/2018 - 01/2017
2	Temozolomide (Temodar)FDA LinkGeneric 01/2018 - 10/2017
2	Bortezomib (Velcade)FDA Link 01/2018 - 04/2013
2	Methylprednisolone FDA LinkGeneric 01/2018 - 01/2013
2	(2,4- dihydroxy- 5- isopropylphenyl)- (5- (4- methylpiperazin- 1- ylmethyl)- 1,3- dihydroisoindol- 2- yl)methanoneIBA 01/2016 - 01/2015
2	Imatinib Mesylate (Gleevec)FDA Link 02/2015 - 01/2015
2	Lenalidomide (CC 5013)FDA Link 03/2012 - 02/2005
2	Peptides (Polypeptides)IBA 09/2011 - 01/2008
2	amuvatinibIBA 12/2009 - 05/2009
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 05/2009 - 03/2009
2	Phosphatidylinositols (Phosphatidylinositol)IBA 09/2008 - 09/2004
1	MethyltransferasesIBA 03/2024
1	olaparibIBA 01/2024
1	NivolumabIBA 01/2023
1	folfirinoxIBA 12/2022
1	Capecitabine (Xeloda)FDA Link 12/2022
1	Ifosfamide FDA LinkGeneric 01/2022
1	Toll-Like Receptor 9IBA 01/2022
1	130-nm albumin-bound paclitaxelIBA 01/2022
1	AZD 6244IBA 01/2022
1	NucleosidesIBA 01/2022
1	Uridine KinaseIBA 01/2022
1	dinaciclibIBA 01/2022
1	fluorocyclopentenylcytosineIBA 01/2022

Therapy/Procedure

41	Therapeutics 02/2024 - 10/2004
8	Drug Therapy (Chemotherapy) 07/2019 - 09/2005
4	Immunotherapy 01/2022 - 11/2018
4	Radiotherapy 01/2021 - 12/2009
3	Aftercare (After-Treatment) 12/2022 - 11/2018
2	Castration 12/2018 - 12/2015
1	Immunomodulation 01/2022
1	Off-Label Use 01/2022